Archives

Annabella: Breast Bump Company Secures $8.5 Million In Funding

By Annie Baker ● Jan 5, 2024

Annabella - a first-of-its-kind breast pump - recently announced its seed funding round of $8.5 million and its entrance into the U.S. market. The notable investors include Israel Shark Tank’s Yasmin Lukatz (Founder of Israel Collaboration Network), serial entrepreneur and investor Oren Dobronsky, as well as Zohar Gilon (Tamar Technology Ventures), and Menachem Weinfeld (Starry Group).

Perplexity: AI Search Company Raises $73.6 Million At A Reported $520 Million Valuation

By Amit Chowdhry ● Jan 5, 2024

Perplexity recently announced milestones reinforcing the company’s increasingly dominant role in this new era of AI-native search. Since publicly launching the world’s first fully functional conversational answer engine about a year ago, the company has grown to 10 million monthly active users and served over half a billion queries last year.

Why APA Is Buying Callon Petroleum For $4.5 Billion

By Annie Baker ● Jan 5, 2024

APA Corporation and Callon Petroleum Company have entered into a definitive agreement under which APA will buy Callon in an all-stock transaction valued at approximately $4.5 billion, inclusive of Callon's net debt.

Ceretype Neuromedicine: Functional MRI Company Raises $2 Million

By Noah Long ● Jan 5, 2024

Ceretype Neuromedicine - a pioneer in the practical application and integration of functional MRI (fMRI) - recently announced that it has closed its second round of seed financing. And the company’s $2 million funding target was oversubscribed.

Pixis: Helping Brands Scale Marketing Through Accessible Codeless AI Technology

By Amit Chowdhry ● Jan 5, 2024

Pixis is a global tech company that develops accessible codeless AI technology to help brands scale all aspects of their marketing and augment their decision-making in a world of infinitely complex consumer behavior. Pulse 2.0 interviewed Pixis co-founder and Chief Business Officer Hari Valiyath to learn more about the company.

NANO Nuclear Energy: How This Company Is Powering The Future Of Advanced Reactors

By Amit Chowdhry ● Jan 5, 2024

NANO Nuclear Energy is a company that has taken the initiative to also focus on High-Assay Low-Enriched Uranium (HALEU) to power the future of advanced reactors through their subsidiary HALEU Energy Fuel Inc. Pulse 2.0 interviewed NANO Nuclear Founder, Executive Chairman and President Jay Jiang Yu and NANO Nuclear Energy’s CEO and Head of Reactor Development, James Walker.

BeatBox: How This Original Party Punch Quickly Grew Into A Beverage Powerhouse

By Amit Chowdhry ● Jan 5, 2024

BeatBox is an "Original Party Punch," offering fun and nostalgic flavors in a sustainable and resealable package. The company's journey started in 2012 in the live music capital of the world, Austin, TX. Pulse 2.0 interviewed BeatBox VP of Global Marketing, Zech Francis, to learn more about the company.

Digitate: Using AI/ML To Help Companies Become More Efficient

By Amit Chowdhry ● Jan 5, 2024

Digitate is a company that leverages machine learning and artificial intelligence (AI) to manage IT and business operations. Pulse 2.0 interviewed Digitate product owner Shouvik Banerjee to learn more about the company.

The Bettering Company: A Socially Responsible Cannabis Edibles Brand Rapidly Growing In A $30+ Billion Market

By Amit Chowdhry ● Jan 5, 2024

The Bettering Company is a socially responsible cannabis edibles brand offering high-quality, hand-crafted, vegan and gluten-free edibles. Pulse 2.0 interviewed The Bettering Company CEO and co-founder Mark Cozzi to learn more about the company.

Trepwise: How This Consulting Firm Unlocks The Potential of Purpose-Driven Organizations

By Amit Chowdhry ● Jan 5, 2024

Trepwise is a strategy consulting firm focused on unlocking the potential of purpose-driven organizations by aligning people, processes, and vision. Pulse 2.0 interviewed Trepwise founder and CEO Kevin Wilkins to learn more about the company.

One Point One Solutions: The Story Behind This Business Process Management Company

By Amit Chowdhry ● Jan 5, 2024

One Point One Solutions is a leading next-generation Business Process Management (BPM) company that offers solutions to some of India's most loved brands. Pulse 2.0 interviewed One Point One Solutions managing director Akshay Chhabra to learn more about the company.

Graviton Bioscience Receives Financing From Enavate Sciences

By Noah Long ● Jan 4, 2024

Graviton Bioscience - a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2) - recently announced the completion of financing from Enavate Sciences, a portfolio company of Patient Square Capital.

Intel And DigitalBridge Form Articul8 To Offer Enterprise GenAI Software Platform

By Amit Chowdhry ● Jan 4, 2024

Intel and global investment firm DigitalBridge Group announced the formation of Articul8 AI, an independent company offering enterprise customers a full-stack, vertically-optimized, and secure generative artificial intelligence (GenAI) software platform. And the platform delivers AI capabilities that keep customer data, training, and inference within the enterprise security perimeter.

Forward Consumer Partners: Debut Fund Closed At $425 Million Hard Cap

By Amit Chowdhry ● Jan 4, 2024

Forward Consumer Partners - a private equity firm that invests in branded consumer businesses - announced recently the successful closing of its oversubscribed debut fund, Forward Fund I (Fund I).

iGrafx: Transforming Process Intelligence To Drive Business Outcomes

By Amit Chowdhry ● Jan 4, 2024

iGrafx is a global leader in process intelligence, enabling the world’s enterprises to turn processes into a competitive advantage. Pulse 2.0 interviewed iGrafx chief executive officer Alexandre Wentzo to learn more about the company.

Vasa Therapeutics Raises $6 Million In Seed Funding To Develop Therapies For Cardiovascular Aging Diseases

By Dan Anderson ● Jan 4, 2024

Vasa Therapeutics - a preclinical stage biopharmaceutical company developing novel therapies for cardiovascular aging - recently announced the closing of $6 million in series seed funding led by Orphinic Scientific SA. The funding round also included participation from private investment funds NuFund Venture Group, SeedFolio, and others.

Radionetics Oncology: $52.5 Million Secured To Advance Radiopharmaceutical Pipeline

By Annie Baker ● Jan 4, 2024

Radionetics Oncology - a clinical-stage radiopharmaceutical company focused on discovering and developing novel agents for treating a wide range of oncology indications - recently announced the completion of a $52.5 million Series A financing. The funding round was led by Frazier Life Sciences, 5AM Ventures, and new investor, DCVC Bio, with participation from Crinetics Pharmaceuticals and GordonMD Global Investments, raising the total to $82.5 million.

Aqua Security: $60 Million Funding Raised At Over $1 Billion Valuation

By Amit Chowdhry ● Jan 4, 2024

Aqua Security - a pioneer in cloud-native security - recently announced it had secured $60 million in funding, led by new investor Evolution Equity Partners, with participation from existing investors Insight Partners, Lightspeed Venture Partners, and StepStone Group. The funding - which is an extension of the company’s Series E round - placed Aqua’s valuation above $1 billion.

Vita Inclinata: $44 Million Closed To Create A Safety Ecosystem For Rescue Crews

By Noah Long ● Jan 4, 2024

Vita Inclinata Technologies - an innovator in intelligent lifting hardware and software for rescue crews and other field safety applications - recently announced that it secured $44 million in funding from 3&1 Fund, a global leader in IP (Intellectual Property) based financing solutions. Utilizing a debt structure, 3&1 Fund offered a compelling alternative to traditional equity-based venture capital financing, which will boost Vita Inclinata Technologies' expansion initiatives.

Remix Therapeutics: $60 Million Raised To Develop Small Molecule Therapies To Modulate RNA Processing

By Amit Chowdhry ● Jan 4, 2024

Remix Therapeutics - a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease - recently announced closing a $60 million financing led by The Column Group.

BioCentriq: Cell-Based Therapy CDMO Company Secures $29.2 Million

By Annie Baker ● Jan 4, 2024

BioCentriq - a global cell-based therapy Contract Development and Manufacturing Organization (CDMO) - recently announced the successful completion of its latest round of fundraising, securing $29.2 million in capital investment. The funding round presents a significant milestone in BioCentriq's mission to accelerate the delivery of innovative cell therapies by translating, optimizing, and scaling processes for GMP manufacture.

Why SentinelOne Is Buying PingSafe

By Amit Chowdhry ● Jan 3, 2024

SentinelOne - a global leader in AI-powered security - announced today that it has agreed to acquire PingSafe. The acquisition of PingSafe’s cloud-native application protection platform (CNAPP) - when combined with SentinelOne’s cloud workload security and cloud data security capabilities - will provide companies with a fully integrated platform that drives better coverage, hygiene, and automation across their entire cloud footprint.

Apollo Therapeutics: Second Close Of Series C Funding Brings Total Raised To $260 Million

By Annie Baker ● Jan 3, 2024

Apollo Therapeutics - a portfolio biopharmaceutical company focused on translating fundamental medical research into medicines through a hub-and-spoke approach - recently announced that during December 2023, it completed a second close of its Series C financing, raising an additional $33.5 million and bringing the total raised in this round by the company during 2023 to $260 million.

NewSpring: Fourth Growth Equity Healthcare Fund Exceeds Target At Over $180 Million

By Amit Chowdhry ● Jan 3, 2024

NewSpring - a family of private equity strategies investing in the lower-middle market - recently announced the final close of its oversubscribed fourth healthcare fund NewSpring Health Capital IV (NSH IV), raising over $180 million.

Franklin Templeton Completes Putnam Investments Acquisition

By Dan Anderson ● Jan 3, 2024

Franklin Resources - a global investment management organization operating as Franklin Templeton - recently announced the successful completion on January 1, 2024, of its acquisition of Putnam Investments from Great-West Lifeco. Per the terms of the deal, Great-West becomes a long-term shareholder in Franklin Resources, consistent with Great-West’s continuing commitment to asset management.

Robin AI: Legal Copilot Company Secures $26 Million

By Noah Long ● Jan 3, 2024

EIG To Buy Ocyan For $390 Million: Details

By Annie Baker ● Jan 3, 2024

EIG - a leading institutional investor in the global energy and infrastructure sectors - recently announced that it has entered into definitive agreements with Novonor S.A. and Brazilian Development Bank (BNDES) to acquire Ocyan Participações S.A., a Brazilian-based solutions provider to the offshore oil and gas industry, for a total amount of $390 million, considering $283 million for Novonor’s 100% equity interest and the remaining amount for liquidation of its outstanding balance of non-voting securities related to the company.

Luna: $50 Million In Funding And Silixa Acquisition

By Amit Chowdhry ● Jan 3, 2024

Luna Innovations - a global leader in advanced fiber optic-based technology - recently announced a $50 million investment by White Hat Capital Partners, an investment firm focused on sustainable value creation in technology companies serving mission-critical applications. The proceeds from this strategic investment were partially used to fund the acquisition of Silixa and related transaction costs in the aggregate amount of approximately $25 million.

Shield AI: Aircraft AI Pilot Company Expands Series F Funding Round To $500 Million

By Amit Chowdhry ● Jan 3, 2024

Shield AI - a defense technology company building the best AI pilot for aircraft - recently announced the expansion of their Series F funding round to $500 million. An additional $100 million in equity, raised at the Series F price, and $200 million in debt from Hercules Capital were added to the initial $200 million in equity closed in November.

Heranova Lifesciences: $13.5 Million Raised To Develop Women’s Health Solutions

By Annie Baker ● Jan 3, 2024

Heranova Lifesciences Holding Ltd. recently announced the successful completion of a $13.5 million seed and seed+ financing to develop and offer integrated Women's Health solutions worldwide. This funding round will be used to launch a series of non-invasive endometriosis tests and advance two innovative (non-hormonal and non-antibiotic) therapeutic programs for endometriosis and bacterial vaginosis.